Trastuzumab 440 mg: Treatment of patients with breast cancer
Created 1 month ago by marykudro

Trastuzumab 440mg Injection is authorized to treat patients with breast cancer and stomach cancer. This Injection is a monoclonal IgG1 recombinant antibody. The trastuzumab 440 mg price can vary. In order to get the details of price and procurement, kindly contact us at TOLL-FREE: 1800-889-1064. Trastuzumab 440 mg blocks the human epidermal growth factor receptor proteins, responsible for cancer cell proliferation in stomach/breast cancer cells. It inhibits several types of cancer and pathways of downstream signalling caused by cancer. Trastuzumab 440 mg is administered through injection into a vein by a health specialist. It is administered usually once every week or once every three weeks.